A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 96.86
GOOG 593.18
MSFT 44.46
BAC 15.59
FB 74.96

Recently Added

BRK-B 128.31
PSX 82.32
P 28.56
APP 1.04
IEX 79.25

Gaining Speed

BRK-B 128.31
PSX 82.32
IEX 79.25
P 28.56
APP 1.04

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!